|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Genomma Lab Internacional, S.A.B. de C.V.
Main Activities: Chemical Manufacturing - Pharmaceutical and Medicine Manufacturing - Scientific Research and Development Services - Research and Development in Biotechnology
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Genomma Lab Internacional, S.A.B. de C.V. Headquarters Edificio Samara, Antonio Dovali Jaime no. 70 Piso 2 Colonia Santa Fe.; Mexico City - Alvaro Obregon ; Federal District of Mexico City; 01210 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational RFC: GLI961030TU5 Financial Auditors: Deloitte Touche Tohmatsu (2012) Incorporation Date: July 30, 2008 Total Employees: 1,380 Tel: +52 (55) 5081 0000 |
|
Company Description |
|
Genomma Lab S.A.B. de C.V. is a pharmaceutical research company, manufacturer and seller of pharmaceutical and cosmetic products. It has strong presence not only in Mexico but also exports its products to more than 30 countries. It has offices in Spain, Argentina, Peru and China. Genomma Lab was established in 1996 as a publicity company for direct consumers with the capacity of producing infomercials for TV. In 2004 a private investment fund operated by "Nexxus Capital", which is a Mexican |
||
|
||
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
FULL COMPANY PROFILE
|
|
2012 Q3C (cons) |
2012 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
XXX |
XXX |
| ||
Current Assets |
XXX |
XXX |
| ||
Total Liabilities |
XXX |
XXX |
| ||
Shareholders Equity |
XXX |
XXX |
| ||
Current Liabilities |
XXX |
XXX |
| ||
| * All the accounts are in MXN. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XXX |
| ||
Operational Profit (Loss) |
XXX |
XXX |
| ||
Net Profit (Loss) |
XXX |
XXX |
| ||
| * All the accounts are in MXN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XXX |
XXX |
| ||
Annualised Return on Assets (ROA) |
XXX |
XXX |
| ||
Return on Equity (ROE) |
XXX |
XXX |
| ||
Annualised Return on Equity (ROE) |
XXX |
XXX |
| ||
Return on Sales (ROS) |
XXX |
XXX |
| ||
Return on Capital |
XXX |
XXX |
| ||
Gross Profit Margin |
XXX |
XXX |
| ||
Operating Profit Margin |
XXX |
XXX |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
XXX |
XXX |
| ||
Inventory Turnover |
XXX |
XXX |
| ||
Current asset turnover |
XXX |
XXX |
| ||
Fixed-asset turnover |
XXX |
XXX |
| ||
Asset Turnover |
XXX |
XXX |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
XXX |
| ||
EBITDA |
XXX |
XXX |
| ||
Enterprise value |
XXX |
XXX |
| ||
Enterprise Value / EBITDA |
XXX |
XXX |
| ||
Bookvalue (BV) |
XXX |
XXX |
| ||
Net Cash |
XXX |
XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX |
XXX |
| ||
Quick ratio |
XXX |
XXX |
| ||
Doom's day ratio |
XXX |
XXX |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX |
XXX |
| ||
Interest Coverage Ratio |
XXX |
XXX |
| ||
Debt to equity |
XXX |
XXX |
| ||
Debt to total assets |
XXX |
XXX |
| ||
Long Term Debt to Capital |
XXX |
XXX |
| ||
Debt / Enterprise Value |
XXX |
XXX |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
XXX |
XXX |
| ||
Market Cap / Net cash |
XXX |
XXX |
| ||
 |